Automated and Closed Cell Therapy Market Research 2024-2029 Featuring Leading Players - Danaher, Thermo Fischer Scientific, Lonza, and Sartorius
September 24, 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Automated and Closed Cell Therapy Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the global market...
KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-004EX, a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte (eTIL®) Therapy
September 24, 2024 07:00 ET
|
KSQ
KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-004EX, a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte (eTIL®) Therapy
Cell & Gene Therapy Manufacturing Services Market Size Worth US$ 70.7 Billion by 2032, Amid Rising Clinical Trials | Research by SNS Insider
September 17, 2024 08:45 ET
|
SNS Insider pvt ltd
Pune, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cell & Gene Therapy Manufacturing Services Market Analysis: “The Cell & Gene Therapy Manufacturing Services Market is experiencing rapid growth,...
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
September 16, 2024 07:00 ET
|
Abata
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035)
September 16, 2024 05:12 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells,...
NMDP℠ Organizes Nationwide Fundraisers to Propel Research, Aid Patients with Blood Cancer and Diseases
September 13, 2024 09:00 ET
|
NMDP
NMDP, a global leader in cell therapy, will host its first-ever community event series, NMDP: Unite to help find cures for blood cancers and diseases.
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
September 09, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024 07:00 ET
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and...
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
September 05, 2024 04:00 ET
|
Laverock Therapeutics
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...